EE200200595A - Hemostaatiliselt aktiivne vWF sisaldav ravimpreparaat ja meetod selle valmistamiseks - Google Patents

Hemostaatiliselt aktiivne vWF sisaldav ravimpreparaat ja meetod selle valmistamiseks

Info

Publication number
EE200200595A
EE200200595A EEP200200595A EEP200200595A EE200200595A EE 200200595 A EE200200595 A EE 200200595A EE P200200595 A EEP200200595 A EE P200200595A EE P200200595 A EEP200200595 A EE P200200595A EE 200200595 A EE200200595 A EE 200200595A
Authority
EE
Estonia
Prior art keywords
vwf
fraction
preparation
active
pharmaceutical composition
Prior art date
Application number
EEP200200595A
Other languages
English (en)
Estonian (et)
Inventor
Josic Djuro
Stadler Monika
Gruber Gerhard
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of EE200200595A publication Critical patent/EE200200595A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
EEP200200595A 2000-04-18 2001-04-04 Hemostaatiliselt aktiivne vWF sisaldav ravimpreparaat ja meetod selle valmistamiseks EE200200595A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108430A EP1148063A1 (de) 2000-04-18 2000-04-18 Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
PCT/EP2001/003819 WO2001079260A1 (de) 2000-04-18 2001-04-04 Haemostatisch aktives vwf enthaltendes präparat und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
EE200200595A true EE200200595A (et) 2004-04-15

Family

ID=8168496

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200595A EE200200595A (et) 2000-04-18 2001-04-04 Hemostaatiliselt aktiivne vWF sisaldav ravimpreparaat ja meetod selle valmistamiseks

Country Status (24)

Country Link
US (2) US7166709B2 (sr)
EP (2) EP1148063A1 (sr)
JP (1) JP4976634B2 (sr)
KR (1) KR100685448B1 (sr)
CN (1) CN100448888C (sr)
AT (1) ATE306494T1 (sr)
AU (2) AU2001263835B2 (sr)
BR (1) BR0110193A (sr)
CA (1) CA2406626C (sr)
CZ (1) CZ303932B6 (sr)
DE (1) DE50107689D1 (sr)
DK (1) DK1274721T3 (sr)
EA (1) EA006209B1 (sr)
EE (1) EE200200595A (sr)
ES (1) ES2247117T3 (sr)
HU (1) HU225992B1 (sr)
IL (2) IL152173A0 (sr)
MX (1) MXPA02010017A (sr)
NO (1) NO324773B1 (sr)
RS (1) RS50835B (sr)
SI (1) SI1274721T1 (sr)
UA (1) UA76714C2 (sr)
WO (1) WO2001079260A1 (sr)
ZA (1) ZA200208396B (sr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
ITLU20070007A1 (it) * 2007-05-07 2008-11-08 Kedrion Spa Processo cromatografico per l'ottenimento di un complesso fviii/vwf con differenti rapporti tra le due proteine da utilizzare nella terapia della emofilia a e nella malattia di von willebrand.
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
SG187410A1 (en) 2007-12-28 2013-02-28 Baxter Int Recombinant vwf formulations
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
PL2291523T3 (pl) 2008-06-24 2015-05-29 Csl Behring Gmbh Czynnik VIII, czynnik von Willebranda lub ich kompleksy o wydłużonym okresie półtrwania in vivo
EP2349314B1 (en) 2008-10-21 2013-02-27 Baxter International Inc. Lyophilized recombinant vwf formulations
IT1396528B1 (it) * 2009-01-19 2012-12-14 Kedrion Spa Nuovo processo di purificazione altamente selettivo di due proteine plasmatiche: von willebrand factor (vwf) e fibronectina (fn).
JP5973997B2 (ja) * 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血用組成物を作製するためのプロセス
RU2603103C2 (ru) * 2010-09-20 2016-11-20 Октафарма Аг Способ получения фибриногена с использованием сильной анионообменной смолы и содержащий фибриноген продукт
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
US10064406B2 (en) * 2011-01-06 2018-09-04 Cytosorbents Corporation Polymeric sorbent for removal of impurities from whole blood and blood products
MX351340B (es) 2012-03-13 2017-10-11 Octapharma Ag Proceso mejorado para la produccion de fibrinogeno y fibrinogeno producido por este.
JP2015515482A (ja) 2012-04-24 2015-05-28 ノヴォ ノルディスク アー／エス 血友病の治療に適する化合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
CN116284337A (zh) * 2023-03-30 2023-06-23 同路生物制药有限公司 以冷沉淀peg沉淀及色谱层析法制备血友病因子的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3878245D1 (de) 1988-11-05 1993-03-18 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
FR2673632A1 (fr) * 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4437544A1 (de) * 1994-10-20 1996-04-25 Behringwerke Ag Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika
US6005077A (en) 1995-11-10 1999-12-21 Immuno Aktiengesellschaft Use of von willebrand factor and pharmaceutical formulation
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
AT404358B (de) * 1997-02-04 1998-11-25 Immuno Ag Verfahren zur chromatographischen reinigung bzw. fraktionierung von von willebrand-faktor aus einem vwf-hältigen ausgangsmaterial
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
IL152173A (en) 2007-07-24
CN1425024A (zh) 2003-06-18
US7166709B2 (en) 2007-01-23
CZ303932B6 (cs) 2013-07-03
WO2001079260A1 (de) 2001-10-25
US20030138913A1 (en) 2003-07-24
SI1274721T1 (sl) 2006-04-30
ATE306494T1 (de) 2005-10-15
HUP0301211A2 (hu) 2003-07-28
BR0110193A (pt) 2003-02-11
CN100448888C (zh) 2009-01-07
RS50835B (sr) 2010-08-31
IL152173A0 (en) 2003-05-29
CA2406626C (en) 2012-02-21
CZ20023454A3 (cs) 2003-05-14
NO20025007D0 (no) 2002-10-17
AU2001263835B2 (en) 2005-06-09
JP2004516231A (ja) 2004-06-03
KR100685448B1 (ko) 2007-02-23
EA200201104A1 (ru) 2003-04-24
HU225992B1 (en) 2008-02-28
JP4976634B2 (ja) 2012-07-18
EP1274721B1 (de) 2005-10-12
ZA200208396B (en) 2004-04-30
YU78402A (sh) 2006-08-17
EP1148063A1 (de) 2001-10-24
HUP0301211A3 (en) 2005-12-28
EP1274721A1 (de) 2003-01-15
DE50107689D1 (de) 2006-02-23
MXPA02010017A (es) 2003-04-25
US20070232791A1 (en) 2007-10-04
NO20025007L (no) 2002-11-28
CA2406626A1 (en) 2001-10-25
PL358388A1 (en) 2004-08-09
KR20030019352A (ko) 2003-03-06
US7985846B2 (en) 2011-07-26
NO324773B1 (no) 2007-12-10
ES2247117T3 (es) 2006-03-01
UA76714C2 (uk) 2006-09-15
EA006209B1 (ru) 2005-10-27
AU6383501A (en) 2001-10-30
DK1274721T3 (da) 2006-02-13

Similar Documents

Publication Publication Date Title
EE200200595A (et) Hemostaatiliselt aktiivne vWF sisaldav ravimpreparaat ja meetod selle valmistamiseks
UA11061A (uk) Спосіб розділеhhя білків крові
CA2248960A1 (en) Stable factor viii/vwf-complex
DE69738768D1 (de) Analyse und separation von pdgf-proteinen
ATE192486T1 (de) Chondroitinase, herstellungsverfahren und pharmazeutische zusammensetzung
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
BR9004626A (pt) Processo para preparar um concentrado estavel de complexo de fator viii-fator de von willebrand,concentrado de complexo de fator viii-fator de von willebrand e concentrados de proteina derivados de plasma
CA2253246A1 (en) Purified multimerase
DK0567448T3 (da) Fremgangsmåde til fremstilling af faktor VIII
JP2579217B2 (ja) 凝固因子▲ｉｉ▼、▲ｖｉｉ▼、▲ｉｘ▼およびｘの１または２以上を濃縮する方法
DK316984D0 (da) Fremgangsmaade til oploesning af peptider
Mazurier et al. In vitro study of a triple‐secured von Willebrand factor concentrate
DE69804325D1 (de) Desinfektion durch partikelgebundene und insolubilisierte detergentien
DE3750664D1 (de) Throminbindende Substanz und Verfahren zu ihrer Herstellung.
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
Danishefsky et al. Photoaffinity labeling of platelet thrombin-binding proteins
DK59785D0 (da) Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf
ATE374812T1 (de) Methode zur herstellung von thrombin
KR960023054A (ko) 재조합 인간 에리스로포이에틴의 정제 방법
KR970073604A (ko) 재조합 b형 간염 표면 항원의 정제방법
RU94028220A (ru) Способ получения целлюлозного перевязочного материала, обладающего антибактериальной и регенеративной активностью
RU94025626A (ru) Способ выделения с5 компонента комплемента человека
KR940003567A (ko) 면역글로불린 a 및 m이 제거된 정맥주사용 감마글로불린제의 제조방법
RU95103423A (ru) Способ выделения, очистки и концентрирования нуклеиновых кислот